Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

661 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Role of Nutraceuticals in Statin Intolerant Patients.
Banach M, Patti AM, Giglio RV, Cicero AFG, Atanasov AG, Bajraktari G, Bruckert E, Descamps O, Djuric DM, Ezhov M, Fras Z, von Haehling S, Katsiki N, Langlois M, Latkovskis G, Mancini GBJ, Mikhailidis DP, Mitchenko O, Moriarty PM, Muntner P, Nikolic D, Panagiotakos DB, Paragh G, Paulweber B, Pella D, Pitsavos C, Reiner Ž, Rosano GMC, Rosenson RS, Rysz J, Sahebkar A, Serban MC, Vinereanu D, Vrablík M, Watts GF, Wong ND, Rizzo M; International Lipid Expert Panel (ILEP). Banach M, et al. Among authors: nikolic d. J Am Coll Cardiol. 2018 Jul 3;72(1):96-118. doi: 10.1016/j.jacc.2018.04.040. J Am Coll Cardiol. 2018. PMID: 29957236 Free article. Review.
The role of fibrate treatment in dyslipidemia: an overview.
Katsiki N, Nikolic D, Montalto G, Banach M, Mikhailidis DP, Rizzo M. Katsiki N, et al. Among authors: nikolic d. Curr Pharm Des. 2013;19(17):3124-31. doi: 10.2174/1381612811319170020. Curr Pharm Des. 2013. PMID: 23317397 Review.
Effects of statins on lipid profile in chronic kidney disease patients: a meta-analysis of randomized controlled trials.
Nikolic D, Nikfar S, Salari P, Rizzo M, Ray KK, Pencina MJ, Mikhailidis DP, Toth PP, Nicholls SJ, Rysz J, Abdollahi M, Banach M; Lipid and Blood Pressure Meta-Analysis Collaboration Group. Nikolic D, et al. Curr Med Res Opin. 2013 May;29(5):435-51. doi: 10.1185/03007995.2013.779237. Epub 2013 Mar 11. Curr Med Res Opin. 2013. PMID: 23427811 Review.
Uric acid metabolism in pre-hypertension and the metabolic syndrome.
Rizzo M, Obradovic M, Labudovic-Borovic M, Nikolic D, Montalto G, Rizvi AA, Mikhailidis DP, Isenovic ER. Rizzo M, et al. Among authors: nikolic d. Curr Vasc Pharmacol. 2014;12(4):572-85. doi: 10.2174/1570161111999131205160756. Curr Vasc Pharmacol. 2014. PMID: 23627979 Review.
Emerging approaches for the treatment of hypertriglyceridemia.
Rizzo M, Perez-Martinez P, Nikolic D, Montalto G, Lopez-Miranda J. Rizzo M, et al. Among authors: nikolic d. Expert Opin Pharmacother. 2013 Oct;14(14):1869-73. doi: 10.1517/14656566.2013.823402. Epub 2013 Sep 6. Expert Opin Pharmacother. 2013. PMID: 24011268
A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important?
Nikolic D, Banach M, Nikfar S, Salari P, Mikhailidis DP, Toth PP, Abdollahi M, Ray KK, Pencina MJ, Malyszko J, Rysz J, Rizzo M; Lipid and Blood Pressure Meta-Analysis Collaboration Group. Nikolic D, et al. Int J Cardiol. 2013 Oct 15;168(6):5437-47. doi: 10.1016/j.ijcard.2013.08.060. Epub 2013 Aug 28. Int J Cardiol. 2013. PMID: 24016544
Statins and new-onset diabetes.
Barylski M, Nikolic D, Banach M, Toth PP, Montalto G, Rizzo M. Barylski M, et al. Among authors: nikolic d. Curr Pharm Des. 2014;20(22):3657-64. doi: 10.2174/13816128113196660678. Curr Pharm Des. 2014. PMID: 24040871 Review.
661 results